Neuren Pharmaceuticals Annual Report 2018

COVER 1
WHY INVEST IN NEUREN? 3
CHAIRMAN’S LETTER 4
OPERATING REVIEW 5
LEADERSHIP TEAM 16
CORPORATE GOVERNANCE 18
DIRECTORS’ REPORT 24
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME 28
CONSOLIDATED STATEMENT OF FINANCIAL POSITION 29
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY 30
CONSOLIDATED STATEMENT OF CASH FLOWS 31
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS 32
INDEPENDENT AUDITOR’S REPORT 48
ADDITIONAL INFORMATION 51

RkJQdWJsaXNoZXIy MjE2NDg3